{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T16:18:15Z","timestamp":1791303495800,"version":"4.1.0"},"reference-count":61,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2008,3,1]],"date-time":"2008-03-01T00:00:00Z","timestamp":1204329600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biological Psychiatry"],"published-print":{"date-parts":[[2008,3]]},"DOI":"10.1016\/j.biopsych.2007.05.030","type":"journal-article","created":{"date-parts":[[2007,8,28]],"date-time":"2007-08-28T07:18:35Z","timestamp":1188285515000},"page":"609-618","source":"Crossref","is-referenced-by-count":203,"title":["Hypometabolism and Altered Cerebrospinal Fluid Markers in Normal Apolipoprotein E E4 Carriers with Subjective Memory Complaints"],"prefix":"10.1016","volume":"63","author":[{"given":"Lisa","family":"Mosconi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"De Santi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miroslaw","family":"Brys","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wai H.","family":"Tsui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Pirraglia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lidia","family":"Glodzik-Sobanska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth E.","family":"Rich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Remigius","family":"Switalski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pankaj D.","family":"Mehta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Domenico","family":"Pratico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ray","family":"Zinkowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kay","family":"Blennow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mony J.","family":"de Leon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopsych.2007.05.030_bib1","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1126\/science.8346443","article-title":"Gene dose of apolipoprotein E type 4 Allele and the risk of Alzheimer\u2019s disease in late onset families","volume":"261","author":"Corder","year":"1993","journal-title":"Science"},{"key":"10.1016\/j.biopsych.2007.05.030_bib2","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1001\/jama.1997.03550160069041","article-title":"Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer Disease","volume":"278","author":"Farrer","year":"1997","journal-title":"JAMA"},{"key":"10.1016\/j.biopsych.2007.05.030_bib3","doi-asserted-by":"crossref","first-page":"6037","DOI":"10.1073\/pnas.090106797","article-title":"Cerebral metabolic and cognitive decline in persons at genetic risk for Alzheimer\u2019s disease","volume":"97","author":"Small","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.biopsych.2007.05.030_bib4","doi-asserted-by":"crossref","first-page":"3334","DOI":"10.1073\/pnas.061509598","article-title":"Declining brain activity in cognitively normal apolipoprotein E epsilon 4 heterozygotes: A foundation for using positron emission tomography to efficiently test treatments to prevent Alzheimer\u2019s disease","volume":"98","author":"Reiman","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.biopsych.2007.05.030_bib5","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1073\/pnas.2635903100","article-title":"Functional brain abnormalities in young adults at genetic risk for late-onset Alzheimer\u2019s dementia","volume":"101","author":"Reiman","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.biopsych.2007.05.030_bib6","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1001\/archpsyc.63.4.442","article-title":"Perceived loss of memory ability and cerebral metabolic decline in persons with the apolipoprotein E-IV genetic risk for Alzheimer disease","volume":"63","author":"Ercoli","year":"2006","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.biopsych.2007.05.030_bib7","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1002\/ana.410420114","article-title":"Metabolic reduction in the posterior cingulate cortex in very early Alzheimer\u2019s Disease","volume":"42","author":"Minoshima","year":"1997","journal-title":"Ann Neurol"},{"key":"10.1016\/j.biopsych.2007.05.030_bib8","doi-asserted-by":"crossref","first-page":"2332","DOI":"10.1212\/01.WNL.0000147469.18313.3B","article-title":"MCI conversion to dementia and the APOE genotype: A prediction study with FDG-PET","volume":"63","author":"Mosconi","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.biopsych.2007.05.030_bib9","first-page":"1625","article-title":"Prediction of individual outcome in MCI by means of genetic assessment and 18F-FDG PET","volume":"46","author":"Drzezga","year":"2005","journal-title":"J Nucl Med"},{"key":"10.1016\/j.biopsych.2007.05.030_bib10","doi-asserted-by":"crossref","first-page":"10966","DOI":"10.1073\/pnas.191044198","article-title":"Prediction of cognitive decline in normal elderly subjects with 2-[18F]fluoro-2-deoxy-D-glucose\/positron-emission tomography (FDG\/PET)","volume":"98","author":"de Leon","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.biopsych.2007.05.030_bib11","article-title":"Hippocampal hypometabolism predicts cognitive decline from normal aging","author":"Mosconi","year":"2007","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.biopsych.2007.05.030_bib12","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1001\/archneur.59.8.1267","article-title":"Differential diagnosis of Alzheimer disease with cerebrospinal fluid levels of tau protein phosphorylated at threonine 231","volume":"59","author":"Buerger","year":"2002","journal-title":"Arch Neurol"},{"key":"10.1016\/j.biopsych.2007.05.030_bib13","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1002\/1531-8249(200011)48:5<809::AID-ANA19>3.0.CO;2-9","article-title":"Increased 8,12-iso-iPF2alpha-VI in Alzheimer\u2019s disease: Correlation of a noninvasive index of lipid peroxidation with disease severity","volume":"48","author":"Pratico","year":"2000","journal-title":"Ann Neurol"},{"key":"10.1016\/j.biopsych.2007.05.030_bib14","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.neurobiolaging.2005.07.003","article-title":"Longitudinal CSF and MRI biomarkers improve the diagnosis of mild cognitive impairment","volume":"27","author":"de Leon","year":"2006","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.biopsych.2007.05.030_bib15","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/S1474-4422(06)70355-6","article-title":"Association between CSF biomarkers and incipient Alzheimer\u2019s disease in patients with mild cognitive impairment: A follow-up study","volume":"5","author":"Hansson","year":"2006","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.biopsych.2007.05.030_bib16","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1001\/archneur.64.3.noc60123","article-title":"Cerebrospinal fluid tau\/beta-amyloid42 ratio as a prediction of cognitive decline in nondemented older adults","volume":"64","author":"Fagan","year":"2007","journal-title":"Arch Neurol"},{"key":"10.1016\/j.biopsych.2007.05.030_bib17","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/j.biopsych.2004.07.021","article-title":"Cerebrospinal fluid beta-amyloid1-42 and tau in control subjects at risk for Alzheimer\u2019s disease: The effect of APOE epsilon4 allele","volume":"56","author":"Sunderland","year":"2004","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.biopsych.2007.05.030_bib18","doi-asserted-by":"crossref","first-page":"2116","DOI":"10.1212\/01.WNL.0000128088.08695.05","article-title":"APOE epsilon4 allele is associated with reduced cerebrospinal fluid levels of Abeta42","volume":"62","author":"Prince","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.biopsych.2007.05.030_bib19","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0304-3940(99)00644-8","article-title":"Cerebrospinal fluid levels of amyloid beta-peptide1-42, but not tau have positive correlation with brain glucose metabolism in humans","volume":"273","author":"Okamura","year":"1999","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.biopsych.2007.05.030_bib20","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.biopsych.2004.05.014","article-title":"Association of elevated phospho-tau levels with Alzheimer-typical 18F-fluoro-2-deoxy-D-glucose positron emission tomography findings in patients with mild cognitive impairment","volume":"56","author":"Fellgiebel","year":"2004","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.biopsych.2007.05.030_bib21","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S0140-6736(74)91496-2","article-title":"Multi-infarct dementia, a cause of mental deterioration in the elderly","volume":"2","author":"Hachinski","year":"1974","journal-title":"Lancet"},{"key":"10.1016\/j.biopsych.2007.05.030_bib22","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1212\/WNL.48.6.1508","article-title":"Clinical dementia rating training and reliability in multicenter studies: The Alzheimer\u2019s Disease Cooperative Study experience","volume":"48","author":"Morris","year":"1997","journal-title":"Neurology"},{"key":"10.1016\/j.biopsych.2007.05.030_bib23","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1176\/ajp.139.9.1136","article-title":"The global deterioration scale for assessment of primary degenerative dementia","volume":"139","author":"Reisberg","year":"1982","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.biopsych.2007.05.030_bib24","first-page":"629","article-title":"The Brief Cognitive Rating Scale (BCRS)","volume":"24","author":"Reisberg","year":"1988","journal-title":"Psychopharmacol Bull"},{"key":"10.1016\/j.biopsych.2007.05.030_bib25","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1001\/archneur.57.1.100","article-title":"Plasma and cerebrospinal fluid levels of amyloid beta proteins 1-40 and 1-42 in Alzheimer disease","volume":"57","author":"Mehta","year":"2000","journal-title":"Arch Neurol"},{"key":"10.1016\/j.biopsych.2007.05.030_bib26","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0304-3940(00)01178-2","article-title":"Detection of tau phosphorylated at threonine 231 in cerebrospinal fluid of Alzheimer\u2019s disease patients","volume":"287","author":"Kohnken","year":"2000","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.biopsych.2007.05.030_bib27","first-page":"567","article-title":"Leukoencephalopathy in normal and pathologic aging: 2","volume":"7","author":"George","year":"1986","journal-title":"AJNR Am J Neuroradiol"},{"key":"10.1016\/j.biopsych.2007.05.030_bib28","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/S0197-4580(01)00230-5","article-title":"Hippocampal formation glucose metabolism and volume losses in MCI and AD","volume":"22","author":"De Santi","year":"2001","journal-title":"Neurobiol Aging"},{"issue":"suppl 5","key":"10.1016\/j.biopsych.2007.05.030_bib29","first-page":"S16","article-title":"Prognosis with dementia in Europe: A collaborative study of population-based cohorts","volume":"54","author":"Jagger","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.biopsych.2007.05.030_bib30","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1111\/j.1471-4159.1977.tb10649.x","article-title":"The [14C]deoxyglucose method for the measurement of local cerebral glucose utilization: Theory, procedure, and normal values in the conscious and anesthetized albino rat","volume":"28","author":"Sokoloff","year":"1977","journal-title":"J Neurochem"},{"key":"10.1016\/j.biopsych.2007.05.030_bib31","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1038\/jcbfm.1985.24","article-title":"Glucose metabolic rate kinetic model parameter determination in humans: The lumped constants and rate constants for [18F]fluorodeoxyglucose and [11C]deoxyglucose","volume":"5","author":"Reivich","year":"1985","journal-title":"J Cereb Blood Flow Metab"},{"key":"10.1016\/j.biopsych.2007.05.030_bib32","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1002\/hbm.460020402","article-title":"Statistical parametric maps in functional imaging: A general linear approach","volume":"2","author":"Friston","year":"1995","journal-title":"Hum Brain Mapp"},{"key":"10.1016\/j.biopsych.2007.05.030_bib33","series-title":"Co-Planar Stereotaxic Atlas of the Human Brain","author":"Talairach","year":"1988"},{"key":"10.1016\/j.biopsych.2007.05.030_bib34","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1212\/01.WNL.0000163856.13524.08","article-title":"Reduced hippocampal metabolism in mild cognitive impairment and Alzheimer\u2019s disease: Automated FDG-PET image analysis","volume":"64","author":"Mosconi","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.biopsych.2007.05.030_bib35","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1176\/ajp.156.4.531","article-title":"Association between memory complaints and incident Alzheimer\u2019s disease in elderly people with normal baseline cognition","volume":"156","author":"Geerlings","year":"1999","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.biopsych.2007.05.030_bib36","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1192\/bjp.171.4.373","article-title":"Subjective memory complaints in the elderly: Depressive symptoms and future dementia","volume":"171","author":"Schmand","year":"1997","journal-title":"Br J Psychiatry"},{"key":"10.1016\/j.biopsych.2007.05.030_bib37","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1176\/appi.ajp.159.3.474","article-title":"Combined analysis of CSF tau levels and [(123)I]Iodoamphetamine SPECT in mild cognitive impairment: Implications for a novel predictor of Alzheimer\u2019s disease","volume":"159","author":"Okamura","year":"2002","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.biopsych.2007.05.030_bib38","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1006\/exnr.2000.7501","article-title":"CSF phosphorylated tau protein and mild cognitive impairment: A prospective study","volume":"166","author":"Arai","year":"2000","journal-title":"Exp Neurol"},{"key":"10.1016\/j.biopsych.2007.05.030_bib39","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1212\/WNL.59.4.627","article-title":"CSF tau protein phosphorylated at threonine 231 correlates with cognitive decline in MCI subjects","volume":"59","author":"Buerger","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.biopsych.2007.05.030_bib40","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1001\/archneur.59.6.972","article-title":"Increase of brain oxidative stress in mild cognitive impairment: A possible predictor of Alzheimer disease","volume":"59","author":"Pratico","year":"2002","journal-title":"Arch Neurol"},{"key":"10.1016\/j.biopsych.2007.05.030_bib41","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.1001\/jama.289.16.2094","article-title":"Decreased {beta}-amyloid1-42 and increased tau levels in cerebrospinal fluid of patients with Alzheimer disease","volume":"289","author":"Sunderland","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.biopsych.2007.05.030_bib42","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1176\/appi.ajp.160.2.376","article-title":"Differentiation of geriatric major depression from Alzheimer\u2019s disease with CSF tau protein phosphorylated at threonine 231","volume":"160","author":"Buerger","year":"2003","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.biopsych.2007.05.030_bib43","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.neurobiolaging.2004.12.003","article-title":"Dissociation between CSF total tau and tau protein phosphorylated at threonine 231 in Creutzfeldt-Jakob disease","volume":"27","author":"Buerger","year":"2006","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.biopsych.2007.05.030_bib44","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1212\/01.WNL.0000070185.02546.5D","article-title":"Enhanced brain levels of 8,12-iso-iPF2{alpha}-VI differentiate AD from frontotemporal dementia","volume":"61","author":"Yao","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.biopsych.2007.05.030_bib45","doi-asserted-by":"crossref","first-page":"510","DOI":"10.5858\/2001-125-0510-CFATAF","article-title":"Cerebrospinal fluid abeta42, tau, and f2-isoprostane concentrations in patients with Alzheimer disease, other dementias, and in age-matched controls","volume":"125","author":"Montine","year":"2001","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.biopsych.2007.05.030_bib46","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1034\/j.1600-0404.107.s179.9.x","article-title":"Cerebrospinal fluid levels of total-tau, phospho-tau and A beta 42 predicts development of Alzheimer\u2019s disease in patients with mild cognitive impairment","volume":"179","author":"Andreasen","year":"2003","journal-title":"Acta Neurol Scand Suppl"},{"key":"10.1016\/j.biopsych.2007.05.030_bib47","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1001\/archneur.59.11.1729","article-title":"Cerebrospinal fluid tau and B-amyloid 42 proteins identify Alzheimer disease in subjects with mild cognitive impairment","volume":"59","author":"Riemenschneider","year":"2002","journal-title":"Arch Neurol"},{"key":"10.1016\/j.biopsych.2007.05.030_bib48","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1212\/01.WNL.0000156914.16988.56","article-title":"CSF A{beta}42 and tau or phosphorylated tau and prediction of progressive mild cognitive impairment","volume":"64","author":"Herukka","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.biopsych.2007.05.030_bib49","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1126\/science.275.5300.630","article-title":"Alzheimer\u2019s disease: Genotypes, phenotype, and treatments","volume":"275","author":"Selkoe","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.biopsych.2007.05.030_bib50","first-page":"671","article-title":"Memory complaints in patients with normal cognition are associated with smaller hippocampal volumes","volume":"251","author":"van der Flier","year":"2004","journal-title":"J Neurol"},{"key":"10.1016\/j.biopsych.2007.05.030_bib51","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1212\/01.wnl.0000234032.77541.a2","article-title":"Older adults with cognitive complaint show brain atrophy similar to that of amnestic MCI","volume":"67","author":"Saykin","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.biopsych.2007.05.030_bib52","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1093\/brain\/122.8.1519","article-title":"Neocortical and hippocampal glucose hypometabolism following neurotoxic lesions of the entorhinal and perirhinal cortices in the non-human primate as shown by PET","volume":"122","author":"Meguro","year":"1999","journal-title":"Brain"},{"key":"10.1016\/j.biopsych.2007.05.030_bib53","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/S0140-6736(85)90965-1","article-title":"A new definition of Alzheimer\u2019s disease: A hippocampal dementia","volume":"1","author":"Ball","year":"1985","journal-title":"Lancet"},{"key":"10.1016\/j.biopsych.2007.05.030_bib54","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1002\/ana.20009","article-title":"Imaging brain amyloid in Alzheimer\u2019s disease with Pittsburgh Compound-B","volume":"55","author":"Klunk","year":"2004","journal-title":"Ann Neurol"},{"key":"10.1016\/j.biopsych.2007.05.030_bib55","doi-asserted-by":"crossref","first-page":"2652","DOI":"10.1056\/NEJMoa054625","article-title":"PET of brain amyloid and tau in mild cognitive impairment","volume":"355","author":"Small","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.biopsych.2007.05.030_bib56","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/S0306-4522(99)00476-5","article-title":"The histological validation of post mortem magnetic resonance imaging-determined hippocampal volume in Alzheimer\u2019s disease","volume":"95","author":"Bobinski","year":"2000","journal-title":"Neuroscience"},{"key":"10.1016\/j.biopsych.2007.05.030_bib57","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1097\/00005072-199704000-00010","article-title":"Relationships between regional neuronal loss and neurofibrillary changes in the hippocampal formation and duration and severity of Alzheimer disease","volume":"56","author":"Bobinski","year":"1997","journal-title":"J Neuropath Exp Neurol"},{"key":"10.1016\/j.biopsych.2007.05.030_bib58","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1212\/WNL.58.5.750","article-title":"Antemortem MRI findings correlate with hippocampal neuropathology in typical aging and dementia","volume":"58","author":"Jack","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.biopsych.2007.05.030_bib59","first-page":"113","article-title":"Post-mortem regional neurofibrillary tangle densities but not senile plaque densities are related to regional cerebral metabolic rates for glucose life in Alzheimer\u2019s disease patients","volume":"1","author":"DeCarli","year":"1992","journal-title":"Neurodegeneration"},{"key":"10.1016\/j.biopsych.2007.05.030_bib60","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1093\/brain\/awf185","article-title":"Cerebral perfusion SPET correlated with Braak pathological stage in Alzheimer\u2019s disease","volume":"125","author":"Bradley","year":"2002","journal-title":"Brain"},{"key":"10.1016\/j.biopsych.2007.05.030_bib61","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1161\/01.STR.29.2.388","article-title":"Relationship between ApoE, MRI findings, and cognitive function in the Cardiovascular Health Study","volume":"29","author":"Kuller","year":"1998","journal-title":"Stroke"}],"container-title":["Biological Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006322307005641?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006322307005641?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,2,17]],"date-time":"2024-02-17T11:34:00Z","timestamp":1708169640000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006322307005641"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,3]]},"references-count":61,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2008,3]]}},"alternative-id":["S0006322307005641"],"URL":"https:\/\/doi.org\/10.1016\/j.biopsych.2007.05.030","relation":{},"ISSN":["0006-3223"],"issn-type":[{"value":"0006-3223","type":"print"}],"subject":[],"published":{"date-parts":[[2008,3]]}}}